Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with epithelial ovarian cancer

Overview of attention for article published in Cochrane database of systematic reviews, February 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

So far, Altmetric has seen 1 blog post.

Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with epithelial ovarian cancer …